SCHEMBL5803149

SCHEMBL5803149

ClP(Cl)(Cl)(Cl)Cl.Clc1nc(-c2ccccc2)c2ccccc2n1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.70
ALDH1A1 P00352 7/20 0.70
LMNA P02545 5/20 0.58
MAPT P10636 4/20 0.58
HPGD P15428 4/20 0.55
GLA P06280 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
NUDT1 P36639 3/20 0.55
ADORA2A P29274 2/20 0.55
KMT2A Q03164 4/20 0.51
OPRK1 P41145 1/20 0.51
MEN1 O00255 3/20 0.50
GAA P10253 3/20 0.50
NPSR1 Q6W5P4 1/20 0.49
PKM P14618 1/20 0.48
ATM Q13315 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
HTT P42858 1/20 0.47
RAD52 P43351 1/20 0.46
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL808420 0.94 KDM4E (0.77) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL17286874 0.91 KDM4E (0.77) KDM4EALDH1A1LMNAMAPTHPGD
Hydrochloric Acid SCHEMBL5803147 0.91 KDM4E (0.72) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL808191 0.91 KDM4E (0.77) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL4087331 0.85 KDM4E (0.75) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL17299607 0.84 KDM4E (0.69) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL20258996 0.84 ALDH1A1 (0.68) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL15810834 0.84 ALDH1A1 (0.63) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL17299602 0.83 KDM4E (0.67) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL22607015 0.82 KDM4E (0.71) KDM4EALDH1A1LMNAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685115-A1 NOVEL NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Warner-Lambert Company LLC (US) 2006-08-02 EP disclosed
WO-2005042501-A1 NOVEL NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY LLC (US) 2005-05-12 WO disclosed